EVALUATION OF TÜRKİYE'S COVID-19 DATA AND THE STATUS IN THE WORLD
Abstract views: 236
/ 
PDF downloads: 121
DOI:
https://doi.org/10.55433/gsbd.239Keywords:
COVID-19, Türkiye, COVID-19 Statistics, World Health OrganizationAbstract
In this study, COVID-19 data announced by the Ministry of Health (2020-2021) were analyzed and Türkiye's situation in the world was evaluated by comparing it with other countries according to the World Health Organization data. The number of COVID-19 cases in Türkiye increased by 229.3% in 2021 compared to 2020, the number of deaths due to COVID-19 increased by 194.4% and the number of tests increased by 285.7%. In 2021, it is seen that there are serious increases in both the number of cases and the number of deaths compared to the figures of 2020. However, the case/death rates are gradually decreasing. Türkiye's case-based death rate was 9.45 per thousand in 2020, 8.4 per thousand in 2021 and 2.93 per thousand according to the data until July 2022. The top five countries reporting the most cases; USA, India, Brazil, France and Germany. Among the top 20 countries reporting the highest number of cases, the countries with the highest mortality rate due to the case (per thousand); Mexico 52.10, Indonesia 25.64, Colombia 22.62, Russia 20.67, Brazil 20.49, Iran 19.51 , Argentina 13.70, India 12.04 and the USA 11.55 per thousand. While the case-related death rate in the world was 20.84 per thousand in 2021, this rate was 11.45 per thousand as of July 2022. Although the number of cases due to COVID-19 has increased worldwide, it is seen that the death rate has decreased. In Turkey, the death rate per case is 6.52 per thousand. We can say that the health infrastructure is strong and the policies implemented are effective in the fight against COVID-19 in Türkiye.
References
McIntosh, K, COVID-19: Epidemiology, virology, and prevention, Section Editor: Hirsch M. S, Deputy Editor: Bloom, A.
Sönmez, F., & Sönmez, C. (2022). Turkey and Europe data comparison in terms of the course of the COVID-19 pandemic and health expenses. Family Practice & Palliative Care, 7(2), 55-58.
Eriş, H., & Ayhan, Z. (2020). Covid-19 perceptions and attitudes of health workers in Turkey. Journal of Critical Reviews, 7(12), 1142-1150.
Şirin, H. & Özkan, Ş. (2020). “Dünyada ve Türkiye’de COVID-19 Epidemiyolojisi”. KBB ve BBC Dergisi. 2020;28(Suppl):S6-S13
Aral, N., & Bakır, H. (2022). Spatiotemporal Analysis of COVID-19 in Turkey. Sustainable Cities and Society, 76, 103421, 1-10.
Çağatay, A., Arslan, Ü. Koyuncu, S. Savaş, A.Y (2022). Acil Servise Başvuran Covid-19 Tanısı Almış Hastalarda Vaka Ölüm Oranlarının İncelenmesi (Türkiye’deki Bir Devlet Hastanesi Örneği) . Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi , 11 (1) , 1-10 . DOI: 10.37989/gumussagbil.100315
Çağatay, A. , Arslan, Ü. & Yılmaz, S. (2021). The Effect Of The Covid-19 Pandemic On Health Services. International Scientific and Vocational Studies Journal , 5 (2) , 218-229 . DOI: 10.47897/bilmes.1035948
Çoban, T. Atış, T.H. Okyay, P. (2022) Covid-19 Pandemisinde Dünyada Güncel Durum. https://hasuder.org.tr/wp-content/uploads/HASUDER-COVID_19-RAPOR-HAZIRAN-2022.pdf
Knutson V, Aleshin-Guendel S, Karlinsky A, Msemburi W, & Wakefield J. Estimating Global and Country-Specific Excess Mortality During the COVID-19 Pandemic. arXiv preprint 2022; arXiv:2205.09081.
Coccia,M.(2022) Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats. Environmental Research,Volume 203, January 2022, 111678
CoVDP Situation Report. (2022). COVID-19 Vaccine Delivery Partnership. Malawi: COVID-19 Vaccine Delivery, file:///C:/Users/seda/Downloads/covid-19/CoVDP-SitRep_Issue-4_June.pdf.
WHO. (2022a). COVİD-19 Weekly Epidemiological Update. Global Overview. Downloads/covid-19/20220817_Weekly_Epi_Update_105 (Erişim tarihi: 10 Ağustos 2022).
Asim, N., Badiei, M. & Sopian, K. (2021). “Review of the Valorization Options for the Prope Disposal of Face Masks During the COVID-19 Pandemic”. Environmental Technology&Innovation, 1-15.
Yin-King vd., L. (2021). “Reuse of Face Masks Among Adults in Hong Kong During the COVID-19 Pandemic”. BMC Public Health, 1-11
Yan, Y., Bayham, J., Richter, A. & Fenichel, E. P. (2021). Risk Compensation and Face Mask Mandates During the COVID-19 Pandemic. Scientific Reports, 11(1), 1-11.
Cheng, K., Hing Lam, T., &Leung, C. (2020). “Wearing Face Masks in the Community During the COVID-19 Pandemic: Altruismand Solidarity”. The Lancet, 1-2.
Rab vd., S. (2020). “Face Masks are New Normal After COVID-19 Pandemic”. Diabetes&Metabolic Syndrome: Clinical Research&Reviews, 1617-1619.
Fridman, A., Gershon, R., &Gneezy, A. (2021). “COVID-19 and Vaccine Hesitancy: A Longitudinal Study”. PLOS ONE, 1-12.
Cordina, M., Lauri, M., &Lauri, J. (2021). “Attitudes Towards COVID-19 Vaccination, Vaccine Hesitancy and Intention toTake the Vaccine”. Pharmacy Practice and the Author, 1-9.
Troiano, G., &Nardi, A. (2021). “Vaccine Hesitancy in the Era of COVID-19”. Public Health, 245-251.
Jeyanathan vd., M. (2020). “Immunological Considerations for COVID-19 Vaccine Strategies”. Nature Reviews Immunology, 615-632.
Coustasse vd., A. (2020). “Letter to the Editor: COVID-19 and Vaccine Hesitancy”. Journal of Ambulatory Care Management, 71-75.
Eriş, H. (2022). COVİD-19 Aşı Algısı ve Tutumu Ölçeği Geçerlilik ve Güvenirliliği. Gevher Nesibe Journal Of Medical And Health Sciences, 7(16), 128-136.
Machingaidze, S., &Wiysonge, C. (2021). “Understanding COVID-19 Vaccine Hesitancy”. news&views, 1338-1344.
Şahinöz, T., Şahinöz, S. & Arslan, Ü. (2022). Traces and Effects of Biological Disasters In the World and in Turkey up to Covid-19, ODÜ Tıp Dergisi. 9:(1), p.1-12.
Sağlık Bakanlığı (2022). Genel Koronavirüs Tablosu https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html (Erişim Tarihi: 12 Temmuz 2022).
WHO (2021). WHO Coronavirus Disease (COVID-19) Dash board. https://covid19.who.int/ (Erişim tarihi: 27 Ağustos 2021).
WHO (2022). WHO Coronavirus Disease (COVID-19) Dash board. https://covid19.who.int/ (Erişim tarihi: 12 Temmuz 2022).
Woolf H. M., Chapman D.A. & Lee J. H. (2020). “COVID-19 As The Leading Cause of Death in the United States”. JAMA. Published online December 17, 2020. doi:10.1001/jama.2020.24865
Ahmad, F.B. & Anderson R, N., (2021). “The Leading Causes of Death in the US for 2020” JAMA. Published online March 31, 2021. doi:10.1001/jama.2021.5469
Kaçak H, Yıldız, M.S. (2020) Stringency of government responses to COVID-19 and initial results: A comparison between five European countries and Turkey. Turk Hij Den Biyol Derg. 77(2): 233-242
Cansever, İ. H. & Şenol, O. (2022). Gelişmiş Ülkelerin Sağlık Sistemleri Verimlilikleri ile COVID-19 Performansları İlişkisi Üzerine Bir Araştırma . Anadolu Üniversitesi Sosyal Bilimler Dergisi , 22 (2) , 611-628 . DOI: 10.18037/ausbd.1136367
Downloads
Published
Versions
- 2024-10-21 (2)
- 2022-09-30 (1)
The journal is licensed under a 